The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1-global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis
© 2023. The Author(s), under exclusive licence to The Royal College of Ophthalmologists..
AIMS: To present current expert practice patterns and to formulate a consensus for the management of HSV and VZV AU by uveitis specialists worldwide.
METHODS: A two-round online modified Delphi survey with masking of the study team was conducted. Responses were collected from 76 international uveitis experts from 21 countries. Current practices in the diagnosis and treatment of HSV and VZV AU were identified. A working group (The Infectious Uveitis Treatment Algorithm Network [TITAN]) developed data into consensus guidelines. Consensus is defined as a particular response towards a specific question meeting ≥75% of agreement or IQR ≤ 1 when a Likert scale is used.
RESULTS: Unilaterality, increased intraocular pressure (IOP), decreased corneal sensation and diffuse or sectoral iris atrophy are quite specific for HSV or VZV AU from consensus opinion. Sectoral iris atrophy is characteristic of HSV AU. Treatment initiation is highly variable, but most experts preferred valacyclovir owing to simpler dosing. Topical corticosteroids and beta-blockers should be used if necessary. Resolution of inflammation and normalisation of IOP are clinical endpoints.
CONCLUSIONS: Consensus was reached on several aspects of diagnosis, choice of initial treatment, and treatment endpoints for HSV and VZV AU. Treatment duration and management of recurrences varied between experts.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Eye (London, England) - 38(2024), 1 vom: 01. Jan., Seite 61-67 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Thng, Zheng Xian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.01.2024 Date Revised 25.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41433-023-02630-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359210120 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359210120 | ||
| 003 | DE-627 | ||
| 005 | 20240126231906.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41433-023-02630-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1271.xml |
| 035 | |a (DE-627)NLM359210120 | ||
| 035 | |a (NLM)37419957 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Thng, Zheng Xian |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1-global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2024 | ||
| 500 | |a Date Revised 25.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to The Royal College of Ophthalmologists. | ||
| 520 | |a AIMS: To present current expert practice patterns and to formulate a consensus for the management of HSV and VZV AU by uveitis specialists worldwide | ||
| 520 | |a METHODS: A two-round online modified Delphi survey with masking of the study team was conducted. Responses were collected from 76 international uveitis experts from 21 countries. Current practices in the diagnosis and treatment of HSV and VZV AU were identified. A working group (The Infectious Uveitis Treatment Algorithm Network [TITAN]) developed data into consensus guidelines. Consensus is defined as a particular response towards a specific question meeting ≥75% of agreement or IQR ≤ 1 when a Likert scale is used | ||
| 520 | |a RESULTS: Unilaterality, increased intraocular pressure (IOP), decreased corneal sensation and diffuse or sectoral iris atrophy are quite specific for HSV or VZV AU from consensus opinion. Sectoral iris atrophy is characteristic of HSV AU. Treatment initiation is highly variable, but most experts preferred valacyclovir owing to simpler dosing. Topical corticosteroids and beta-blockers should be used if necessary. Resolution of inflammation and normalisation of IOP are clinical endpoints | ||
| 520 | |a CONCLUSIONS: Consensus was reached on several aspects of diagnosis, choice of initial treatment, and treatment endpoints for HSV and VZV AU. Treatment duration and management of recurrences varied between experts | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Putera, Ikhwanuliman |e verfasserin |4 aut | |
| 700 | 1 | |a Testi, Ilaria |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Westcott, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Chee, Soon-Phaik |e verfasserin |4 aut | |
| 700 | 1 | |a Dick, Andrew D |e verfasserin |4 aut | |
| 700 | 1 | |a Kempen, John H |e verfasserin |4 aut | |
| 700 | 1 | |a Bodaghi, Bahram |e verfasserin |4 aut | |
| 700 | 1 | |a Thorne, Jennifer E |e verfasserin |4 aut | |
| 700 | 1 | |a Barisani-Asenbauer, Talin |e verfasserin |4 aut | |
| 700 | 1 | |a de Smet, Marc D |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Justine R |e verfasserin |4 aut | |
| 700 | 1 | |a McCluskey, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a La Distia Nora, Rina |e verfasserin |4 aut | |
| 700 | 1 | |a Jabs, Douglas A |e verfasserin |4 aut | |
| 700 | 1 | |a de Boer, Joke H |e verfasserin |4 aut | |
| 700 | 1 | |a Sen, H Nida |e verfasserin |4 aut | |
| 700 | 1 | |a Goldstein, Debra A |e verfasserin |4 aut | |
| 700 | 1 | |a Khairallah, Moncef |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Janet L |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenbaum, James T |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Nicholas P |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Quan Dong |e verfasserin |4 aut | |
| 700 | 1 | |a Pavesio, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Rupesh |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Vishali |e verfasserin |4 aut | |
| 700 | 0 | |a TITAN consensus guidelines group |e verfasserin |4 aut | |
| 700 | 1 | |a Zierhut, Manfred |e investigator |4 oth | |
| 700 | 1 | |a Boer, Joke |e investigator |4 oth | |
| 700 | 1 | |a Palestine, Alan |e investigator |4 oth | |
| 700 | 1 | |a Denniston, Alastair K |e investigator |4 oth | |
| 700 | 1 | |a Invernizzi, Alessandro |e investigator |4 oth | |
| 700 | 1 | |a Radgonde, Amer |e investigator |4 oth | |
| 700 | 1 | |a Kumar, Amitabh |e investigator |4 oth | |
| 700 | 1 | |a Curi, Andre |e investigator |4 oth | |
| 700 | 1 | |a Agarwal, Aniruddha |e investigator |4 oth | |
| 700 | 1 | |a Yee, Anita Chan Sook |e investigator |4 oth | |
| 700 | 1 | |a Okada, Annabelle A |e investigator |4 oth | |
| 700 | 1 | |a Schlaen, Ariel |e investigator |4 oth | |
| 700 | 1 | |a Heiligenhaus, Arnd |e investigator |4 oth | |
| 700 | 1 | |a Gurbaxani, Avinash |e investigator |4 oth | |
| 700 | 1 | |a Murugan, S Bala |e investigator |4 oth | |
| 700 | 1 | |a Lee, Cecilia S |e investigator |4 oth | |
| 700 | 1 | |a Das, Dipankar |e investigator |4 oth | |
| 700 | 1 | |a Baglivo, Edoardo |e investigator |4 oth | |
| 700 | 1 | |a Carreño, Ester |e investigator |4 oth | |
| 700 | 1 | |a Arevalo, J Fernando |e investigator |4 oth | |
| 700 | 1 | |a Pichi, Francesco |e investigator |4 oth | |
| 700 | 1 | |a Uy, Harvey |e investigator |4 oth | |
| 700 | 1 | |a Al-Dhibi, Hassan A |e investigator |4 oth | |
| 700 | 1 | |a Garweg, Justus G |e investigator |4 oth | |
| 700 | 1 | |a Biswas, Jyotirmay |e investigator |4 oth | |
| 700 | 1 | |a Murthy, Kalpana Babu |e investigator |4 oth | |
| 700 | 1 | |a Caspers, Laure |e investigator |4 oth | |
| 700 | 1 | |a Cimino, Luca |e investigator |4 oth | |
| 700 | 1 | |a Lim, Lyndell L |e investigator |4 oth | |
| 700 | 1 | |a de la Maza, Maite Sainz |e investigator |4 oth | |
| 700 | 1 | |a Agarwal, Mamta |e investigator |4 oth | |
| 700 | 1 | |a Mochizucki, Manabu |e investigator |4 oth | |
| 700 | 1 | |a Agarwal, Manisha |e investigator |4 oth | |
| 700 | 1 | |a Munk, Marion R |e investigator |4 oth | |
| 700 | 1 | |a Accorinti, Massimo |e investigator |4 oth | |
| 700 | 1 | |a Tyagi, Mudit |e investigator |4 oth | |
| 700 | 1 | |a Acharya, Nisha |e investigator |4 oth | |
| 700 | 1 | |a Mahendradas, Padmamalini |e investigator |4 oth | |
| 700 | 1 | |a Majumder, Parthopratim Dutta |e investigator |4 oth | |
| 700 | 1 | |a Murray, Philip I |e investigator |4 oth | |
| 700 | 1 | |a Lin, Phoebe |e investigator |4 oth | |
| 700 | 1 | |a Neri, Piergiorgio |e investigator |4 oth | |
| 700 | 1 | |a Bansal, Reema |e investigator |4 oth | |
| 700 | 1 | |a Read, Russell W |e investigator |4 oth | |
| 700 | 1 | |a Mehta, Salil |e investigator |4 oth | |
| 700 | 1 | |a Shawki, Samir S Shoughy |e investigator |4 oth | |
| 700 | 1 | |a Mazumdar, Shahana |e investigator |4 oth | |
| 700 | 1 | |a Narain, Shishir |e investigator |4 oth | |
| 700 | 1 | |a Androudi, Sofia |e investigator |4 oth | |
| 700 | 1 | |a Murthy, Somasheila |e investigator |4 oth | |
| 700 | 1 | |a Rathinam, S R |e investigator |4 oth | |
| 700 | 1 | |a Beng, Stephen Teoh Charn |e investigator |4 oth | |
| 700 | 1 | |a Sridharan, Sudharshan |e investigator |4 oth | |
| 700 | 1 | |a Phatak, Sumita |e investigator |4 oth | |
| 700 | 1 | |a Tappeiner, Christoph |e investigator |4 oth | |
| 700 | 1 | |a Lai, Timothy Y Y |e investigator |4 oth | |
| 700 | 1 | |a Yuen, Yew Sen |e investigator |4 oth | |
| 700 | 1 | |a Feng, Yun |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Eye (London, England) |d 1995 |g 38(2024), 1 vom: 01. Jan., Seite 61-67 |w (DE-627)NLM012628646 |x 1476-5454 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:61-67 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41433-023-02630-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2024 |e 1 |b 01 |c 01 |h 61-67 | ||